Tempus AI (NASDAQ:TEM) Shares Gap Down – Time to Sell?

Tempus AI, Inc. (NASDAQ:TEM) gapped down prior to trading on Tuesday . The stock had previously closed at $49.87, but opened at $47.79. Tempus AI shares last traded at $46.51, with a volume of 2,005,129 shares traded.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on TEM shares. Guggenheim reaffirmed a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Bank of America increased their target price on shares of Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd. JPMorgan Chase & Co. downgraded shares of Tempus AI from an “overweight” rating to a “neutral” rating and increased their target price for the stock from $50.00 to $55.00 in a research report on Tuesday, February 25th. Loop Capital lowered their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Finally, TD Cowen reissued a “buy” rating and set a $74.00 target price (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Price Performance

The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The stock’s fifty day simple moving average is $55.86 and its 200-day simple moving average is $51.48.

Insider Buying and Selling at Tempus AI

In related news, CAO Ryan M. Bartolucci sold 13,770 shares of the stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the sale, the chief accounting officer now owns 57,237 shares in the company, valued at approximately $3,434,220. This trade represents a 19.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO James William Rogers sold 23,030 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $45.97, for a total transaction of $1,058,689.10. Following the completion of the sale, the chief financial officer now owns 164,750 shares of the company’s stock, valued at approximately $7,573,557.50. The trade was a 12.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,598,969 shares of company stock worth $317,194,162 over the last ninety days.

Institutional Investors Weigh In On Tempus AI

Hedge funds have recently made changes to their positions in the stock. Kovitz Investment Group Partners LLC bought a new stake in shares of Tempus AI in the third quarter valued at about $1,367,000. China Universal Asset Management Co. Ltd. bought a new stake in shares of Tempus AI in the fourth quarter valued at about $1,091,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Tempus AI during the fourth quarter worth about $178,000. Captrust Financial Advisors bought a new position in Tempus AI during the third quarter worth about $2,726,000. Finally, abrdn plc bought a new position in Tempus AI during the fourth quarter worth about $2,784,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.